[A22-34] Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Extract of the final report: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Final report: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Documentation of comments on the preliminary report: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Preliminary report: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Documentation of comments on the report plan: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence

Report plan: Benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation in severe tobacco dependence